Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Normal Drug Tolerance”

298 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 298 results

Early research (Phase 1)Study completedNCT04100642
What this trial is testing

A Phase I Clinical Study of Hemay808

Who this might be right for
Safety Issues
Tianjin Hemay Pharmaceutical Co., Ltd 42
Testing effectiveness (Phase 2)Study completedNCT01179854
What this trial is testing

Remegal Different Doses in Patients With Refractory Partial Seizures

Who this might be right for
Drug SafetyNormal Drug ToleranceSelf Efficacy
Valexfarm 60
Early research (Phase 1)Study completedNCT01969656
What this trial is testing

Safety Study of an Oral Vitamin D Analog in Postmenopausal Women

Who this might be right for
Postmenopausal Osteoporosis, Multiple Sites
Deltanoid Pharmaceuticals
Testing effectiveness (Phase 2)Ended earlyNCT03094169
What this trial is testing

AVID100 in Advanced Epithelial Carcinomas

Who this might be right for
Solid Tumor, AdultTriple Negative Breast CancerHead and Neck Squamous Cell Carcinoma+1 more
Formation Biologics 49
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06435299
What this trial is testing

Efficacy and Tolerance of THC 25: CBD 25 in Patients With Severe Pruritus: a Multicenter, Double-blind, Randomized, Placebo-controlled Study

Who this might be right for
Pruritus
University Hospital, Brest 218
Not applicableLooking for participantsNCT07071363
What this trial is testing

COMPARISON OF A COSMETIC SERUM AND 4% HYDROQUINONE FOR TREATING MELASMA OVER 84 DAYS

Who this might be right for
HealthyMelasma (Facial Melasma)Epidermal Melasma
Laboratoire Dermatologique ACM 40
Early research (Phase 1)Study completedNCT02482311
What this trial is testing

Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours

Who this might be right for
Ovarian Cancer, TNBC, SCLC, Other Solid Tumours
AstraZeneca 92
Not applicableStudy completedNCT05590364
What this trial is testing

Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands

Who this might be right for
Skin LaxitySkin Roughness
IBSA Farmaceutici Italia Srl 51
Large-scale testing (Phase 3)Study completedNCT02101333
What this trial is testing

Efficacy and Tolerance of Tocilizumab In Takayasu Arteritis

Who this might be right for
TAKAYASU ARTERITIS
Assistance Publique - Hôpitaux de Paris 18
Large-scale testing (Phase 3)Study completedNCT00525616
What this trial is testing

Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid

Who this might be right for
Bullous Pemphigoid
University Hospital, Rouen 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06356740
What this trial is testing

Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Hospices Civils de Lyon 70
Not applicableStudy completedNCT02857062
What this trial is testing

To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin

Who this might be right for
Atopic Dermatitis / Eczema
Reckitt Benckiser Healthcare (UK) Limited 34
Not applicableStudy completedNCT05469880
What this trial is testing

Efficacy and Tolerance of Formula 609613 37 in Acneic Patients

Who this might be right for
Acne
Cosmetique Active International 100
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698979
What this trial is testing

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Who this might be right for
Buerger DiseaseRaynaud Syndrome
University Hospital, Toulouse 8
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07110662
What this trial is testing

New Therapeutic Target for Toxic Epidermal Necrolysis (TEN) Using Anti-CD38+ Monoclonal Antibodies.

Who this might be right for
Toxic Epidermal NecrolysisImmunotherapyCutaneous Adverse Drug Reactions (CADR)
Hospices Civils de Lyon 9
Large-scale testing (Phase 3)Study completedNCT00757562
What this trial is testing

Safety of Desloratadine in Children With Allergy Sensitivity and Chronic Hives, Who Are Poor Metabolizers of Desloratadine (Study P02994)

Who this might be right for
Chronic Idiopathic UrticariaAtopy
Organon and Co 97
Not applicableStudy completedNCT02309424
What this trial is testing

The Effect of Vinegar on Glucose and Lipid Metabolism in Subjects With Impaired Glucose Tolerance or Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Attikon Hospital 20
Large-scale testing (Phase 3)Study completedNCT01022463
What this trial is testing

Effect of Ivabradine on Heart Rate & Effort Tolerance in Mitral Stenosis in Sinus Rhythm

Who this might be right for
Mitral Stenosis
Govind Ballabh Pant Hospital 50
Large-scale testing (Phase 3)Study completedNCT01348386
What this trial is testing

Efficacy and Tolerance of Potassium Hydroxide (10% and 15%) in Molluscum Contagiosum

Who this might be right for
Molluscum Contagiosum
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina 53
Not applicableLooking for participantsNCT01851694
What this trial is testing

Beta-cell Response to Incretin Hormones in Cystic Fibrosis

Who this might be right for
Cystic FibrosisPancreatic Insufficiency
University of Pennsylvania 45
Load More Results